|
1
|
Chai AWY, Lim KP and Cheong SC:
Translational genomics and recent advances in oral squamous cell
carcinoma. Semin Cancer Biol. 61:71–83. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hübbers CU and Akgül B: HPV and cancer of
the oral cavity. Virulence. 6:244–248. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Sasahira T and Kirita T: Hallmarks of
cancer related newly prognostic factors of oral squamous cell
carcinoma. Int J Mol Sci. 19(2413)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huang SH and O'Sullivan B: Overview of the
8th Edition TNM Classification for Head and Neck Cancer. Curr Treat
Options Oncol. 18(40)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Roi A, Roi CI, Negrutiu ML, Rivis M,
Sinescu C and Rusu LC: The Challenges of OSCC diagnosis: Salivary
cytokines as potential biomarkers. J Clin Med.
9(2866)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Campisi G, Calvino F, Carinci F, Matranga
D, Carella M, Mazzotta M, Rubini C, Panzarella V, Santarelli A,
Fedele S, et al: Peri-tumoral inflammatory cell infiltration in
OSCC: A reliable marker of local recurrence and prognosis? An
investigation using artificial neural networks. Int J Immunopathol
Pharmacol. 24:113–120. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kreppel M, Nazarli P, Grandoch A, Safi AF,
Zirk M, Nickenig HJ, Scheer M, Rothamel D, Hellmich M and Zöller
JE: Clinical and histopathological staging in oral squamous cell
carcinoma - comparison of the prognostic significance. Oral Oncol.
60:68–73. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Cristaldi M, Mauceri R, Di Fede O,
Giuliana G, Campisi G and Panzarella V: Salivary biomarkers for
oral squamous cell carcinoma diagnosis and follow-up: Current
Status and Perspectives. Front Physiol. 10(1476)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guo ZC, Jumatai S, Jing SL, Hu LL, Jia XY
and Gong ZC: Bioinformatics and immunohistochemistry analyses of
expression levels and clinical significance of CXCL2 and TANs in an
oral squamous cell carcinoma tumor microenvironment of
Prophyromonas gingivalis infection. Oncol Lett.
21(189)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Berger H, Wodarz A and Borchers A: PTK7
faces the Wnt in development and disease. Front Cell Dev Biol.
5(31)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mossie K, Jallal B, Alves F, Sures I,
Plowman GD and Ullrich A: Colon carcinoma kinase-4 defines a new
subclass of the receptor tyrosine kinase family. Oncogene.
11:2179–2184. 1995.PubMed/NCBI
|
|
12
|
Golubkov VS, Prigozhina NL, Zhang Y,
Stoletov K, Lewis JD, Schwartz PE, Hoffman RM and Strongin AY:
Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility
and metastasis. J Biol Chem. 289:24238–24249. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
González P, González-Fernández C,
Campos-Martín Y, Mollejo M, Carballosa-Gautam M, Marcillo A,
Norenberg M, García-Ovejero D and Rodríguez FJ: Spatio-temporal and
Cellular Expression Patterns of PTK7 in the Healthy and
Traumatically Injured Rat and Human Spinal Cord. Cell Mol
Neurobiol. 40:1087–1103. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bie J, Hu X, Yang M, Shi X, Zhang X and
Wang Z: PTK7 promotes the malignant properties of cancer stem-like
cells in esophageal squamous cell lines. Hum Cell. 33:356–365.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Peradziryi H, Tolwinski NS and Borchers A:
The many roles of PTK7: A versatile regulator of cell-cell
communication. Arch Biochem Biophys. 524:71–76. 2012.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Katoh M: Canonical and non-canonical WNT
signaling in cancer stem cells and their niches: Cellular
heterogeneity, omics reprogramming, targeted therapy and tumor
plasticity (Review). Int J Oncol. 51:1357–1369. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tian X, Yan L, Zhang D, Guan X, Dong B,
Zhao M and Hao C: PTK7 overexpression in colorectal tumors:
Clinicopathological correlation and prognosis relevance. Oncol Rep.
36:1829–1836. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kadioglu O, Saeed MEM, Mahmoud N, Hussein
Azawi SS, Rincic M, Liehr T and Efferth T: Identification of
metastasis-related genes by genomic and transcriptomic studies in
murine melanoma. Life Sci. 267(118922)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nweke EE, Naicker P, Aron S, Stoychev S,
Devar J, Tabb DL, Omoshoro-Jones J, Smith M and Candy G: SWATH-MS
based proteomic profiling of pancreatic ductal adenocarcinoma
tumours reveals the interplay between the extracellular matrix and
related intracellular pathways. PLoS One.
15(e0240453)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Damelin M, Bankovich A, Bernstein J, Lucas
J, Chen L, Williams S, Park A, Aguilar J, Ernstoff E, Charati M, et
al: A PTK7 targeted antibody drug conjugate reduces tumor
initiating cells and induces sustained tumor regressions. Sci
Transl Med. 9(eaag2611)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Duan F, Tang J, Kong FL, Zou HW, Ni BL and
Yu JC: Identification of PTK7 as a promising therapeutic target for
thyroid cancer. Eur Rev Med Pharmacol Sci. 24:6809–6817.
2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sun JJ, Li HL, Guo SJ, Ma H, Liu SJ, Liu D
and Xue FX: The increased PTK7 expression is a malignant factor in
cervical cancer. Dis Markers. 2019(5380197)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bie J, Liu K, Song G, Hu X, Xiong R, Zhang
X, Shi X and Wang Z: ENST00000489707.5 is a preferred alternative
splicing variant of PTK7 in adrenocortical cancer and shows
potential prognostic value. Med Sci Monit. 25:8326–8334.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Chen S, Wang Y, Su Y, Zhang L, Zhang M, Li
X, Wang J and Zhang X: miR 205 5p/PTK7 axis is involved in the
proliferation, migration and invasion of colorectal cancer cells.
Mol Med Rep. 17:6253–6260. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sharma M, Castro-Piedras I, Simmons GE Jr
and Pruitt K: Dishevelled: A masterful conductor of complex Wnt
signals. Cell Signal. 47:52–64. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zou YF, Xie CW, Yang SX and Xiong JP: AMPK
activators suppress breast cancer cell growth by inhibiting
DVL3-facilitated Wnt/β-catenin signaling pathway activity. Mol Med
Rep. 15:899–907. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen XQ, Jiang J, Wang XT, Zhang CL, Ji AY
and Chen XJ: Role and mechanism of Dvl3 in the esophageal squamous
cell carcinoma. Eur Rev Med Pharmacol Sci. 22:7716–7725.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Osathanon T, Nowwarote N and Pavasant P:
Expression and influence of Notch signaling in oral squamous cell
carcinoma. J Oral Sci. 58:283–294. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Dong Y, Chen X, Li H, Ni Y, Han W and Wang
J: PTK7 is a molecular marker for metastasis, TNM stage, and
prognosis in oral tongue squamous cell carcinoma. Pol J Pathol.
68:49–54. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zuo K, Qi Y, Yuan C, Jiang L, Xu P, Hu J,
Huang M and Li J: Specifically targeting cancer proliferation and
metastasis processes: The development of matriptase inhibitors.
Cancer Metastasis Rev. 38:507–524. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zheng XY, Cao MZ, Ba Y, Li YF and Ye JL:
LncRNA testis specific transcript, Y linked 15 (TTTY15) promotes
proliferation, migration and invasion of colorectal cancer cells
via regulating miR 29a 3p/DVL3 axis. Cancer Biomark. 31:1–11.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Fontanals-Cirera B, Hasson D, Vardabasso
C, Di Micco R, Agrawal P, Chowdhury A, Gantz M, de
Pablos-Aragoneses A, Morgenstern A, Wu P, et al: Harnessing BET
inhibitor sensitivity reveals AMIGO2 as a melanoma survival gene.
Mol Cell. 68:731–744.e9. 2017.PubMed/NCBI View Article : Google Scholar
|
